Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial
Biotechnology company Transposon Therapeutics presented the results from its successful phase 2 clinical trial of its experimental medication for ALS/FTD at the 35th International Symposium on ALS/MND. The trial of…
Read MoreAviadoBio CEO Emphasizes Collaborative Approach for Treating FTD
In October, U.K.-based gene therapy company AviadoBio, Ltd., and pharmaceutical company Astellas announced an exclusive option and license agreement for an investigational therapeutic, AVB-101, which is currently in a Phase…
Read MoreJanuary 11, 2025: In-Person Meet & Greet in Middlesex, N.J.
Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event, hosted by AFTD volunteer Norma Edom and AFTD Ambassador Sandra Gonzalez-Morett at…
Read MoreIn-Person Meet & Greet in Middlesex, N.J.
Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event, hosted by AFTD volunteer Norma Edom and AFTD Ambassador Sandra Gonzalez-Morett. RSVP…
Read MoreDear HelpLine: Types of FTD
Dear HelpLine, My mom was recently diagnosed with FTD, and when I visited your website, I learned that there are several types of FTD. My mom wasn’t diagnosed with a…
Read MorePartners in FTD Care: The Heterogeneity of FTD
FTD’s wide variety of symptoms present a challenge to healthcare professionals as they evaluate and treat people who either have the disease or are suspected of having it. FTD disorders…
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)